Filter
30
Text search:
Remnant,
J.
Featured
New Publications
5
Language
Document type
Studies & Reports
11
No document type
11
Guidelines
7
Strategic & Response Plan
1
Countries / Regions
India
7
Ethiopia
1
Syria
1
Malawi
1
Namibia
1
Western and Central Europe
1
Africa
1
Authors & Publishers
Publication Years
Category
Countries
11
Public Health
1
Clinical Guidelines
1
Toolboxes
HIV
11
Planetary Health
2
NTDs
2
Disability
1
Conflict
1
Mental Health
1
COVID-19
1
Caregiver
1
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and innovation in new drugs and diagnostics. Key approaches include implementing national action plans, strengthening laboratory capacity for monitoring, and pr
...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable
...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A
...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun
...
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment.
